Clinical Trial Update: A Feasibility Study to Assess the Use of Gadolinium in Computed Tomography [Phase 4]

View source ↗

Summary

A Phase 4 feasibility study on gadolinium use in CT for patients with contrast media allergy was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast Media Allergy

Drugs mentioned

• Gadolinium (gadolinium-based contrast agent)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Contrast Media Allergy | Phase 4 | Status: WITHDRAWN